Prediction of risk of diabetic retinopathy for all-cause mortality, stroke and heart failure Evidence from epidemiological observational studies

被引:5
作者
Zhu, Xiao-Rong [1 ]
Zhang, Yong-Peng [2 ]
Bai, Lu [3 ]
Zhang, Xue-Lian [1 ]
Zhou, Jian-Bo [1 ]
Yang, Jin-Kui [1 ,4 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing, Peoples R China
[3] Beijing Haidian Hosp, Dept Geratol, Beijing, Peoples R China
[4] Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China
基金
美国国家科学基金会;
关键词
all-cause mortality; diabetic retinopathy; heart failure; stroke; CARDIOVASCULAR-DISEASE; TYPE-1; DYSFUNCTION; ARTERY; COMPLICATIONS; ANGIOGENESIS; METAANALYSIS; ASSOCIATION; NIDDM; OSAKA;
D O I
10.1097/MD.0000000000005894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To examine and quantify the potential relation between diabetic retinopathy (DR) and risk of all-cause mortality, stroke and heart failure (HF). The resources of meta-analysis of epidemiological observational studies were from Pub-med, EMBASE, CINAHL, Cochrane Library, conference, and proceedings. Random/fixed effects models were used to calculate pooled subgroup analysis stratified by different grades of DR was performed to explore the potential source of heterogeneity. Statistical manipulations were undertaken using program STATA. Of the included 25 studies, comprising 142,625 participants, 19 studies were concluded to find the relation of DR to all-cause mortality, 5 for stroke, and 3 for HF. Risk ratio (RR) for all-cause mortality with the presence of DR was 2.33 (95% CI 1.92-2.81) compared with diabetic individuals without DR. Evidences showed a higher risk of all-cause mortality associated with DR in patients with T2D or T1D (RR 2.25, 95% CI 1.91-2.65. RR 2.68, 95% CI 1.34-5.36). According to different grades of DR in patients with T2D, RR for all-cause mortality varied, the risk of nonproliferative diabetic retinopathy (NPDR) was 1.38 (1.11-1.70), while the risk of proliferative diabetic retinopathy (PDR) was 2.32 (1.75-3.06). There was no evidence of significant heterogeneity (Cochran Q test P=0.29 vs 0.26, I-2=19.6% vs 22.6%, respectively). Data from 5 studies in relation to DR and the risk of stroke showed that DR was significantly associated with increased risk of stroke (RR=1.74, 95% CI: 1.35-2.24), compared with patients without DR. Furthermore, DR (as compared with individuals without DR) was associated with a marginal increased risk of HF in patients with diabetes mellitus (DM) (n=3 studies; RR 2.24, 95% CI 0.98-5.14, P=0.056). Our results showed that DR increased the risk of all-cause mortality, regardless of the different stages, compared with the diabetic individuals without DR. DR predicted increased risk of stroke and HF. Although only 3 studies about HF were available, the association between DR and HF should be careful.
引用
收藏
页数:6
相关论文
共 50 条
[31]   Vitamin D intake and risk of CVD and all-cause mortality: evidence from the Caerphilly Prospective Cohort Study [J].
Guo, Jing ;
Cockcroft, John R. ;
Elwood, Peter C. ;
Pickering, Janet E. ;
Lovegrove, Julie A. ;
Givens, David I. .
PUBLIC HEALTH NUTRITION, 2017, 20 (15) :2744-2753
[32]   Association of retinopathy with risk of all-cause and specific-cause mortality in the National Health and Nutrition Examination Survey, 2005 to 2008 [J].
Gui, Si-Yu ;
Wang, Xin-Chen ;
Qiao, Jian-Chao ;
Lin, Si-Yu ;
Wang, Qian-Qian ;
Zhang, Meng-Yue ;
Xu, Yue-Yang ;
Huang, Zhi-Hao ;
Tao, Li-Ming ;
Hu, Cheng-Yang ;
Tao, Fang-Biao ;
Jiang, Zheng-Xuan ;
Liu, Dong-Wei .
FRONTIERS IN PUBLIC HEALTH, 2023, 11
[33]   Change in resting heart rate and risk for all-cause mortality [J].
Ristow, Brandon ;
Doubell, Anton ;
Derman, Wayne ;
Heine, Martin .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (07) :E249-E254
[34]   Ventricular volume asymmetry as a risk marker for heart failure and all-cause mortality in transfusion-dependent thalassemia [J].
Meloni, Antonella ;
Pistoia, Laura ;
Restaino, Gennaro ;
Zerbini, Michela ;
Grassedonio, Emanuele ;
Vallone, Antonino ;
Longo, Filomena ;
Borsellino, Zelia ;
Lisi, Roberto ;
Cecinati, Valerio ;
Spasiano, Anna ;
Rosso, Rosamaria ;
Positano, Vincenzo ;
Clemente, Alberto .
VESSEL PLUS, 2025, 9
[35]   Development and validation of a nomogram model for all-cause mortality risk in patients with chronic heart failure and atrial fibrillation [J].
Guan, Lin ;
Wang, Chuan-He ;
Sun, Hao ;
Sun, Zhi-Jun .
BMC GERIATRICS, 2024, 24 (01)
[36]   β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis [J].
Tianyu Xu ;
Yuli Huang ;
Haobin Zhou ;
Yujia Bai ;
Xingfu Huang ;
Yunzhao Hu ;
Dingli Xu ;
Yuhui Zhang ;
Jian Zhang .
BMC Cardiovascular Disorders, 19
[37]   Association between hysterectomy status and stroke risk and cause-specific and all-cause mortality: evidence from the 2005-2018 National Health and Nutrition Examination Survey [J].
Shen, Ruihuan ;
Wang, Jia ;
Tian, Yuqing ;
Wang, Rui ;
Guo, Peiyao ;
Shen, Shuhui ;
Liu, Donghao ;
Zou, Tong .
FRONTIERS IN NEUROLOGY, 2023, 14
[38]   The Impact of Changes in Fasting Plasma Glucose before and after Heart Failure Diagnosis on All-Cause Mortality [J].
Zhang, Boheng ;
Liu, Xiaokun ;
Wu, Shouling ;
Yang, Jing ;
Yue, Qing ;
Chen, Shuohua ;
Han, Quanle ;
Wang, Wei ;
Zhang, Qi .
CARDIOLOGY, 2025,
[39]   High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population [J].
Zhang, Weili ;
Sun, Kai ;
Chen, Jinxing ;
Liao, Yuhua ;
Qin, Qin ;
Ma, Aiqun ;
Wang, Daowen ;
Zhu, Zhiming ;
Wang, Yibo ;
Hui, Rutai .
CLINICAL SCIENCE, 2010, 118 (3-4) :187-194
[40]   Risk Factors for All-Cause Mortality in Patients Diagnosed with Advanced Heart Failure: A Scoping Review [J].
Kaur, Palvinder ;
George, Pradeep Paul ;
Xian, Sheryl Ng Hui ;
Yip, Wan Fen ;
Seng, Eric Chua Siang ;
Tay, Ri Yin ;
Tan, Joyce ;
Chu, Jermain ;
Low, Zhi Jun ;
Tey, Lee Hung ;
Hoon, Violet ;
Tan, Chong Keat ;
Tan, Laurence ;
Aw, Chia Hui ;
Tan, Woan Shin ;
Hum, Allyn .
JOURNAL OF PALLIATIVE MEDICINE, 2025, 28 (04) :524-537